SeraCare Life Sciences, Inc.-医療機器分野:企業M&A・提携分析

◆英語タイトル:SeraCare Life Sciences, Inc. - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011940
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SeraCare Life Sciences, Inc. (SeraCare) carries out the discovery, development, manufacture and supply of disease-state specimens and tissues for research and development, processed biological materials, immunoassay reagents and quality control products and technologies. Its major products include next-gen sequencing and digital PCR tools, controls and reference materials, validation and lot qualification materials; plasma and serum diluents/derivatives; cell culture reagents; antibodies and conjugates; and immunoassay reagents and kits. SeraCare’s major customers include IVD manufacturers; government and regulatory agencies; and pharmaceutical and biotechnology companies; veterinary companies; and academic and government research organizations. It has facilities in Milford, Massachusetts and Gaithersburg, Maryland. The company distributes its products through a network of distributors in several countries the world over. SeraCare is headquartered in Milford, Massachusetts, the US.

SeraCare Life Sciences, Inc. – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SeraCare Life Sciences, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 5
SeraCare Life Sciences, Inc., Medical Equipment Deals By Type, 2011 to YTD 2017 6
SeraCare Life Sciences, Inc., Medical Equipment, Deals By Region, 2011 to YTD 2017 7
SeraCare Life Sciences, Inc., Medical Equipment, Deals By Market, 2011 to YTD 2017 8
SeraCare Life Sciences, Inc., Medical Equipment, Deals Summary, 2011 to YTD 2017 9
SeraCare Life Sciences, Inc., Medical Equipment, Deal Details 10
Private Equity 10
SeraCare Receives Shareholders Approval For Its Acquisition By Linden Capital For US$82 Million 10
Partnerships 12
SeraCare Life Sciences Enters into Agreement with ArcherDx 12
SeraCare Life Sciences Enters into R&D Agreement with National Institute of Standards and Technology 13
SeraCare Life Sciences Forms Partnership with Toma Biosciences 14
Swift Biosciences Partners with SeraCare Life Sciences 15
SeraCare Life Sciences Enters into Co-Marketing Agreement with ViveBio 16
SeraCare Life Sciences Enters into R&D Agreement with National Cancer Institute 17
Acquisition 18
SeraCare Life Sciences Acquires Kirkegaard & Perry Labs 18
SeraCare Life Sciences, Inc. – Key Competitors 19
SeraCare Life Sciences, Inc. – Key Employees 20
SeraCare Life Sciences, Inc. – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Product News 22
Aug 01, 2017: SeraCare Announces the Launch of a Suite of Zika Virus Reference Materials for Improved Diagnostic Testing 22
Jul 18, 2017: SeraCare Life Sciences Announces the Most Patient-Like cfDNA QC Technology 23
Mar 23, 2017: SeraCare Life Sciences announces launch of industry’s first multiplexed Inherited Cancer reference material 24
Feb 21, 2017: SeraCare Life Sciences Announces New Highly Multiplexed Fusion RNA Assay Reference Standards 25
Feb 08, 2017: SeraCare Life Sciences Announces Presentation on Enabling Clinical Genomics with Highly Multiplexed Reference Materials 26
Nov 11, 2016: SeraCare Launches Two New Seraseq Reference Materials for Clinical Oncology Assays 27
Oct 19, 2016: SeraCare Life Sciences Develops Industry’s First Multiplexed Cardiomyopathy Reference Material 28
Jul 26, 2016: SeraCare Launches New QC Software for Clinical Laboratories Running Next-Generation Sequencing Assays 29
May 09, 2016: SeraCare Launches Industry’s First Recombinant Virus Technology-based AccuPlex Zika Reference Material 30
03/07/2016: SeraCare Launches Circulating Tumor DNA Reference Materials for NGS and Digital PCR-based Oncology Assays 31
Other Significant Developments 32
Nov 08, 2017: SeraCare Announces Industry’s First Comprehensive NGS Reference Material for Hematologic Malignancies 32
Nov 10, 2016: SeraCare Life Sciences to Support Non-Invasive Prenatal Testing (NIPT) Proficiency Program in Collaboration with UK NEQAS 33
Oct 12, 2016: SeraCare Life Sciences Announces Preimplantation Genetic Screening (PGS) Reference Materials Partnership 34
Sep 22, 2016: France-Based Laboratoire CERBA Adopts Seraseq Aneuploidy Reference Materials for Non-Invasive Prenatal Testing 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
SeraCare Life Sciences, Inc., Medical Equipment, Key Facts 2
SeraCare Life Sciences, Inc., Medical Equipment, Deals Summary, 2011 to YTD 2017 2
SeraCare Life Sciences, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 5
SeraCare Life Sciences, Inc., Medical Equipment Deals By Type, 2011 to YTD 2017 6
SeraCare Life Sciences, Inc., Medical Equipment, Deals By Region, 2011 to YTD 2017 7
SeraCare Life Sciences, Inc., Deals By Market, 2011 to YTD 2017 8
SeraCare Life Sciences, Inc., Medical Equipment, Deals Summary, 2011 to YTD 2017 9
SeraCare Receives Shareholders Approval For Its Acquisition By Linden Capital For US$82 Million 10
SeraCare Life Sciences Enters into Agreement with ArcherDx 12
SeraCare Life Sciences Enters into R&D Agreement with National Institute of Standards and Technology 13
SeraCare Life Sciences Forms Partnership with Toma Biosciences 14
Swift Biosciences Partners with SeraCare Life Sciences 15
SeraCare Life Sciences Enters into Co-Marketing Agreement with ViveBio 16
SeraCare Life Sciences Enters into R&D Agreement with National Cancer Institute 17
SeraCare Life Sciences Acquires Kirkegaard & Perry Labs 18
SeraCare Life Sciences, Inc., Key Competitors 19
SeraCare Life Sciences, Inc., Key Employees 20
SeraCare Life Sciences, Inc., Other Locations 21
SeraCare Life Sciences, Inc., Subsidiaries 21

★海外企業調査レポート[SeraCare Life Sciences, Inc.-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SKY Network Television Limited (SKT):企業の財務・戦略的SWOT分析
    SKY Network Television Limited (SKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Avon Products, Inc.:企業の戦略・SWOT・財務情報
    Avon Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Avon Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Robins & Morton LLC:企業の戦略・SWOT・財務情報
    Robins & Morton LLC - Strategy, SWOT and Corporate Finance Report Summary Robins & Morton LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ivy Cosmetics Corporation:企業の戦略・SWOT・財務分析
    Ivy Cosmetics Corporation - Strategy, SWOT and Corporate Finance Report Summary Ivy Cosmetics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Banco di Desio e della Brianza SpA:企業の戦略・SWOT・財務分析
    Banco di Desio e della Brianza SpA - Strategy, SWOT and Corporate Finance Report Summary Banco di Desio e della Brianza SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Adaptimmune Therapeutics Plc (ADAP):製薬・医療:M&Aディール及び事業提携情報
    Summary Adaptimmune Therapeutics Plc (Adaptimmune), formerly Adaptimmune Therapeutics Limited, is a clinical stage biopharmaceutical company that develops innovative T-cell therapy products for the treatment of cancer. It harnesses the proprietary SPEAR (Specific Peptide Enhanced Affinity Receptor) …
  • Breckenridge Pharmaceutical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Breckenridge Pharmaceutical Inc (Breckenridge), a subsidiary of Laboratorios Del Dr Esteve SA is a healthcare solution provider that research, develops and markets various generic prescription products. The company provides products including stradiol, oxcarbazepine tablets, methylprednisolo …
  • Altana Ag:企業の戦略・SWOT・財務分析
    Altana Ag - Strategy, SWOT and Corporate Finance Report Summary Altana Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Enmax Corp:企業の戦略的SWOT分析
    Enmax Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • OncoSec Medical Inc (ONCS)-製薬・医療分野:企業M&A・提携分析
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through i …
  • Companhia Energetica de Minas Gerais SA:発電所・企業SWOT分析
    Companhia Energetica de Minas Gerais SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informat …
  • Universiteit Utrecht-製薬・医療分野:企業M&A・提携分析
    Summary Universiteit Utrecht (Universiteit Utrecht) is a research university that offers education programs. The university offers bachelors, master's, honor education, education for professionals, online education, training and other education courses. Its research areas include earth and sustainab …
  • Owens & Minor Inc (OMI):医療機器:M&Aディール及び事業提携情報
    Summary Owens & Minor Inc (Owens & Minor) is a healthcare services company, which provides supply chain services to healthcare providers and manufacturers of healthcare products. It provides logistics services for disposable medical supplies, devices and implants. Owens & Minor offers medical and su …
  • Pou Sheng International (Holdings) Ltd:戦略・SWOT・企業財務分析
    Pou Sheng International (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Pou Sheng International (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • North Energy ASA (NORTH):企業の財務・戦略的SWOT分析
    Summary North Energy ASA (North Energy) is an upstream oil and gas company that provides exploration and development services in Norwegian Continental Shelf (NCS). The company’s services include oil and gas exploration and development, license mapping and drilling programs, and conducting geological …
  • Navidea Biopharmaceuticals Inc (NAVB)-製薬・医療分野:企業M&A・提携分析
    Summary Navidea Biopharmaceuticals Inc (Navidea) is a precision medicine company that focuses on the development and commercialization of radiopharmaceutical agents and precision diagnostics. Its key product, Lymphoseek (technetium Tc 99m tilmanocept) injection, is a radiopharmaceutical agent used i …
  • Waterloo Industries Inc:企業の戦略的SWOT分析
    Waterloo Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Gujarat State Electricity Corporation Ltd:企業の戦略的SWOT分析
    Gujarat State Electricity Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Votorantim Energia Ltda:企業の戦略的SWOT分析
    Votorantim Energia Ltda - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • NewOcean Energy Holdings Ltd (342):企業の財務・戦略的SWOT分析
    NewOcean Energy Holdings Ltd (342) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆